1. Introduction {#sec1}
===============

Development of new and efficient reaction pathways through the assistance of organocatalysis is a rapidly emerging and dynamic area of research in current chemical science.^[@ref1]^ Organocatalysis has emerged as a powerful and environment-friendly technique for a variety of fundamentally important transformations and preparation of optically pure organic compounds of potential importance.^[@cit1d],[@ref2]^ Among all the oraganocatalytic techniques, conjugate Michael addition reaction for C--C bond formation is one of the most powerful techniques for construction of functionalized and enantiorich carbon skeletons for the synthesis of biologically active compounds.^[@ref3]^ In this regard, conjugate Michael addition reaction to nitro-olefins is also very attractive as the resulting nitroalkane can be converted into several other important functional groups of potential importance.^[@ref4]^ For this purpose, numerous strategies such as Brønsted acid--base interactions,^[@ref5]^ π-stacking interactions,^[@ref6]^ enamine or iminium catalysis,^[@ref7]^ hydrogen bonding interaction through urea or thiourea,^[@ref8]^ ion-pair interactions by phase transfer catalysts,^[@ref9]^ and cage complexes^[@ref10]^ are among the organocatalytic strategies that have been widely utilized.^[@ref11]^ Several functional groups such as functionalized proline,^[@ref12]^ substituted amines,^[@ref13]^ and squaramides^[@ref14]^ were utilized for this purpose. However, organocatalytic Michael addition reactions with cage complexes/capsular assemblies are very rare in the literature.^[@cit10d],[@ref15]^ Because of the formation of a suitable microenvironment inside the cavity, organic transformations inside cage/capsular assemblies are very fascinating, and they come up with exciting and unprecedented results.

Several monopodal, bipodal amine-urea/thiourea-based dual receptors have been utilized for achiral/asymmetric versions of Michael addition reactions.^[@ref16]^ Previously, we reported the first example of a tripodal, monomeric bifunctional tris(2-aminoethyl)-amine-based tripodal pentafluorophenyl urea catalyst (**L1**, [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}) for efficient Michael addition reactions along with its detailed mechanistic investigations.^[@cit8e]^ However, because of the limited solubility of the catalyst in common organic solvents, we could only carry out the reaction in dimethyl sulfoxide (DMSO) with a reaction time of 5--6 h. In order to overcome this limitation of solubility and to reduce the reaction time, we have tried to modify the urea moiety with various substituents. However, all our attempts failed to improve its solubility in common organic solvents. Then, we turned our attention toward the use of dimeric capsular assembly as catalyst to improve the catalyst solubility and introduce other assistances such as the use of a suitable microenvironment, utilization of a greater number of urea units in reaction, and so on. The capsular assembly was prepared by treating the monomer with tetrabutylammonium hydroxide (TBAOH) in DMSO in open atmosphere ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). After 1 or 2 days, crystals of carbonate-encapsulated dimeric assembly were obtained on the liquid--air interface (for details, see the [Experimental Section](#sec4){ref-type="other"} & ref ([@ref17])).

![Schematic Representation of the Formation of Dimeric Carbonate Capsular Assembly, **C1**, from Monomeric Tripodal Urea, **L1**, and Their Use as Catalysts in Michael Addition Reactions of Activated Nucleophiles with Various β-Nitrostyrenes](ao-2018-01780q_0006){#sch1}

The dimeric capsular assembly had two preliminary advantages over its monomer, viz. (i) drastic improvement in solubility is observed (soluble in almost all common organic solvents), which assisted in more convenient reaction and work-up procedures and (ii) capsular cavity is created with basic carbonate anion and six acidic urea units within the capsular cavity, which might assist facile Michael addition reactions via formation of a suitable microenvironment. In order to serve our purpose, we have synthesized a dimeric hexaurea capsular assembly, **C1**, **(TBA)2\[CO**~**3**~**⊂(L1)**~**2**~**\]** from its monomer, **L1**, as described previously and shown in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}. To the best of our knowledge, this is the first ever report of catalytic Michael addition reaction by a purely organic capsular assembly.

2. Results and Discussion {#sec2}
=========================

All the optimization studies were carried out by a model Michael addition reaction between β-nitrostyrene, **2a**, and three equivalents of ethyl acetoacetate, **3a**. The solvent dependence of the catalytic activities of the catalyst has been studied with different solvents such as dichloromethane (DCM), tetrahydrofuran (THF), methanol (MeOH), acetonitrile (CH~3~CN), water (H~2~O), DMSO, and toluene at room temperature. All the reactions were carried out under similar experimental conditions. Among all the solvents, we observed the maximum catalytic activity of the catalyst in DCM and toluene ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). It is noteworthy to mention here that we have removed the limitation of using conventional organic solvents as opposed to our previous report with **L1** where the catalysis could only be performed in DMSO. **C1** showed an almost similar catalytic activity in DMSO, DCM, THF, and toluene where the reaction was completed within only 5 min. However, in the case of polar protic solvents such as MeOH and H~2~O, the reactions took a much longer time with a lower yield of product ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Because of the convenience of using DCM as the solvent as compared to DMSO, toluene, and THF, we have performed all our catalytic reactions in DCM.

###### Optimization of Reaction Condition[a](#t1fn1){ref-type="table-fn"}

![](ao-2018-01780q_0007){#GRAPHIC-d7e304-autogenerated}

  entry   solvent   time (min)   [b](#t1fn2){ref-type="table-fn"}yield (%)
  ------- --------- ------------ -------------------------------------------
  1       DCM       5            95
  2       THF       5            88
  3       MeOH      300          17
  4       CH~3~CN   60           85
  5       H~2~O     300          trace
  6       DMSO      5            93
  7       toluene   5            95

Reaction condition: **2a** (1 equiv), **3a** (3 equiv), and **C1** (10 mol %) in the presence of various solvents at room temperature.

Isolated yield.

After successful optimization of the solvent, we optimized the catalyst loading of the receptor by scanning the catalyst loading from 10 to 1 mol % ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). Data in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"} clearly show that the catalyst is capable of carrying out the reaction efficiently with catalyst loading as low as 1 mol % within only 5 min without any significant decrease in the yield of the product ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}, [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). In case of our previous report, we could reach the minimum catalyst loading of 2 mol % with a reaction time of 5--6 h.^[@cit8e]^ Thus, by using this dimeric capsular assembly, we have reduced the catalyst loading, and also a drastic improvement in reaction time has been achieved.

![Advancement of Michael addition reaction with time: (a) ^1^H NMR of only β-nitrostyrene with trimethoxy benzene as internal standard; (b) ^1^H NMR of the above reaction after 5 min from the addition of ethyl acetoacetate (3 equiv) with 1 mol % **C1**.](ao-2018-01780q_0001){#fig1}

###### Optimization of Catalyst Loading[a](#t2fn1){ref-type="table-fn"}

![](ao-2018-01780q_0008){#GRAPHIC-d7e487-autogenerated}

  entry   catalyst, **C1** (mol %)   time (min)   [b](#t2fn2){ref-type="table-fn"}yield (%)
  ------- -------------------------- ------------ -------------------------------------------
  1       10                         5            95
  2       5                          5            96
  3       2                          5            94
  4       1                          5            95

Reaction condition: **2a** (1 equiv), **3a** (3 equiv) in the presence of various catalyst loadings in DCM at room temperature.

Isolated yield.

2.1. Michael Reaction with Ketoester and 1,3-Dicarbonyl Compounds {#sec2.1}
-----------------------------------------------------------------

The dimeric capsular assembly **C1** has been examined as a catalyst for reaction of various substituted and unsubstituted β-nitrostyrenes (**2a--2d**) with different Michael donors in DCM at room temperature. All the 15 reactions in these series progressed smoothly with good yields of final products (85--97% yield, [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). It can be clearly observed from [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"} that substitution on the phenyl ring of the electrophilic β-nitrostyrenes does not have any significant effect on the overall yield of the product. The reactivity rates of all the β-nitrostyrenes were almost same at room temperature (with 1 mol % catalyst loading and 3 equiv Michael donor) irrespective of the nature of electronic effect on the phenyl ring. However, at a lower temperature, we could differentiate the Michael acceptors based on their electrophilic nature. Primarily, the reactions of ethyl acetoacetate, **3a**, to all the β-nitrostyrenes (**2a--2d**) were investigated with 1 mol % **C1** catalyst in DCM, which yielded the products (**4a--4d**) as diastereomeric mixtures in high yields (93--97% yield, [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). Then, under similar experimental conditions, the reactions between β-nitrostyrenes (**2a--2d**) and acetyl acetones (**3b**) were carried out. Interestingly, only unsubstituted and *p*-OCH~3~-substituted β-nitrostyrenes yielded the desired products (**5a**, **5c**) in good yield (88 and 85%, respectively, [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}), whereas the other two substrates did not form any products as observed from thin-layer chromatography (TLC). Further, diethyl malonate (**3c**) was also employed as a Michael donor toward the above series of Michael acceptors (**2a--2d**). It was noticed that only *p*-CH~3~- and *p*-OCH~3~-substituted β-nitrostyrenes formed the desired Michael addition products (**6b**, **6c**) in good yields (92 and 90%, respectively, [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). Finally, the cyclic ketoester Michael donor, **3e**, was employed in addition reaction with all the previously mentioned β-nitrostyrenes, which yielded all the four desired products (**8a--8d**) in significantly good yields. It is noteworthy to mention here that all the above reactions were completed within only 5 min with 3 equiv donors and 1 mol % catalyst loading.

###### Michael Reaction of β-Nitro Styrenes with Cyanoester, Ketoester, and 1,3-Dicarbonyl Compounds[a](#t3fn1){ref-type="table-fn"}

![](ao-2018-01780q_0009){#gr7}

All yields reported here are isolated yields.

2.2. Michael Reaction with Other Michael Donors {#sec2.2}
-----------------------------------------------

Further, Michael addition reactions of different β-nitrostyrenes (**2a--2d**) with different types of Michael donor substrates, viz. cyano ethylacetate, **3d**, and malononitrile, were carried out under similar experimental conditions as mentioned previously. It is noteworthy to mention that **C1** showed a similar catalytic and kinetic efficiency as shown previously during reaction with 1,3-di carbonyl compounds. **3d** reacted with **2b**, **2c**, and **2d** to give the desired products (**7b**, **7c**, and **7d**) in 84, 85, and 87% yields, respectively ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}), within 5 min with 3 equiv Michael donor and 1 mol % catalyst loading. Interestingly, in all cases, the diastereomeric ratio was found to be 1:1 irrespective of the substituents on the phenyl ring of the Michael acceptors. However, we did not see the formation of our desired products when malononitrile was employed as Michael donor. Probably, in the presence of the highly basic carbonate group, the malononitrile gets decomposed. After performing Michael addition reactions of various Michael donors with different β-nitrostyrenes, in order to investigate the mechanism of the Michael addition reactions, we carried out several kinetic studies based on ^1^H NMR experiments. These studies were performed by monitoring the formation of the product via ^1^H NMR, with 1,3,5-trimethoxybenzene as the internal reference. Initially, when a reaction is carried out between **2a** and excess of ethyl acetoacetate, **3a**, with 1 mol % **C1** catalyst at room temperature, the reaction was completed within such a short time (within 5 min) that it could not be monitored stepwise by ^1^H NMR spectroscopy. Thus, in order to slow down the rate of the reaction (so that some valuable data can be obtained within the NMR time scale), we have performed the reaction by decreasing the temperature of reaction to 0 °C. Then, we were able to record some kinetic data for the reaction where the concentration of starting styrene decreases progressively with time ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). A plot of log(*C*~0~/*C*~*t*~) versus time from the abovementioned reaction yielded a perfectly fitted straight line according to the equation log(*C*~0~/*C*~*t*~) = *K* × *t* (where *C*~0~ is the initial conc. of styrene, *C*~*t*~ is the conc. of styrene at time, *t*, and *K* is the rate constant of the reaction). The linear fitting of the data points clearly indicated that the reaction is pseudo-first-order wrt **2a** with a rate constant value of 1.1 × 10^--1^ min^--1^ ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). It is noteworthy to mention here that this rate constant value is about 70 times higher than the pseudo-first-order rate constant value reported for **L1** for the same reaction in DMSO.^[@cit8e]^ Similarly, the reactions between **2b**, **2c**, and **2d** with excess ethyl acetoacetate resulted in a steady decrease in concentration of starting styrene at 0 °C ([Figures S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01780/suppl_file/ao8b01780_si_001.pdf), [S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01780/suppl_file/ao8b01780_si_001.pdf), and [S5](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01780/suppl_file/ao8b01780_si_001.pdf)), and the plot of log(*C*~0~/*C*~*t*~) versus time yielded a straight line, which indicated all the reactions to be pseudo-first-order wrt **2b**, **2c**, and **2d** ([Figures S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01780/suppl_file/ao8b01780_si_001.pdf), [S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01780/suppl_file/ao8b01780_si_001.pdf), and [S6](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01780/suppl_file/ao8b01780_si_001.pdf)). Fitting of all the above data yielded rate constant values of 9.8 × 10^--2^, 7.8 × 10^--2^, and 1.3 × 10^--1^ min^--1^ for **2b**, **2c**, and **2d**, respectively ([Figures S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01780/suppl_file/ao8b01780_si_001.pdf), [S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01780/suppl_file/ao8b01780_si_001.pdf), and [S6](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01780/suppl_file/ao8b01780_si_001.pdf), [Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}), with increment factors of 98, 82, and 52 times, respectively, as compared to rate constant values reported for **L1** in DMSO.^[@cit8e]^ Similarly, the reaction is found to be pseudo-first-order wrt EAA when a large excess of **2a** was used as reactant ([Figure S7](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01780/suppl_file/ao8b01780_si_001.pdf)).

![Progress of Michael addition reaction between **2a** (0.016 mmol) and **3a** (0.16 mmol) in CDCl~3~ at 0 °C with 1 mol % **C1** monitored by ^1^H NMR in 300 MHz.](ao-2018-01780q_0002){#fig2}

![Kinetic studies based on the integration values obtained from ^1^H NMR: plot of log(*C*~0~/*C*~*t*~) vs time for **2a** (0.016 mmol) and **3a** (0.16 mmol) in CDCl~3~ at 0 °C with 1 mol % **C1**.](ao-2018-01780q_0003){#fig3}

###### Rate Constant (*k*~R~) for the Reaction between Ethyl Acetoacetate and p-Substituted Phenyl β-Nitrostyrene

  entry   R          σ        *k*~R~/min^--1^   *k*~R~/*k*~H~   log(*k*~R~/*k*~H~)
  ------- ---------- -------- ----------------- --------------- --------------------
  1       H          0        1.1 × 10^--1^     1               0
  2       --CH~3~    --0.17   9.8 × 10^--2^     0.875           --0.58
  3       --OCH~3~   --0.27   7.8 × 10^--2^     0.708           --0.13
  4       --Cl       0.22     1.3 × 10^--1^     1.2             0.08

After evaluation of the rate constant of the reactions with several Michael acceptors, we evaluated the Hammett reaction constant (ρ) for determination of extent of electronic perturbation in the transition state of the reaction. The effect of different substituents on the reaction kinetics is generally derived from the Hammett linear free energy relationship, which is formulated as log(*k*~R~/*k*~H~) = ρσ, where (*k*~R~/*k*~H~) is the relative rate constant value for R-substituted β-nitrostyrene as compared to unsubstituted β-nitrostyrene and σ is known as the substituent constant. Thus, a plot of log(*k*~R~/*k*~H~) versus σ yields a straight line with a slope of ρ, which is the measure of the sensitivity of a reaction upon electronic perturbation because of the substituent effect. The parameter, ρ, determines the relative susceptibility of a reaction to the nature of substituent (electron-donating or electron-withdrawing). In our present Michael addition reaction, we have undertaken a Hammett study to investigate the influence of substituents on the phenyl ring of nitrostyrene, on the Michael addition reactions. A plot of relative rate constant (*k*~R~/*k*~H~) versus substituent constant, σ, resulted in a linear fit of the data points with positive Hammett reaction constant ρ-value of 0.4 ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}), which indicated that the reaction proceeded through a nucleophilic mechanism. A positive ρ value suggests that the nucleophilic attack of enolate on the nitrostyrene produces an anionic intermediate which is likely to be stabilized by H-bonding interaction with the urea moiety.

![Hammett plot of the Michael reaction of p-substituted β-nitrostyrene with **3a**.](ao-2018-01780q_0004){#fig4}

In order to investigate the role of the capsular cavity in the course of the reaction, we have performed some controlled reactions where at first a combination of **L1** and Na~2~CO~3~ (as 10 mol % catalyst) was used as a catalyst. This catalyst was used in the Michael addition reaction between β-nitrostyrene (**2a**) with three equivalents of ethyl acetoacetate (**3a**) in DCM at room temperature. Interestingly, TLC showed a very small amount of conversion of reactant (β-nitrostyrene) even after 2--3 h. In fact, the catalyst combination is not at all soluble in DCM, which resulted in heterogeneous phase catalysis (as opposed to **C1** where the reaction medium was homogeneous) that could not efficiently produce the desired Michael addition product. This result indicated that the capsular cavity remained stable (if the capsule were broken, the reaction medium would become heterogeneous as monomeric **L1** is insoluble in DCM) during the reaction and assisted the reaction inside the cavity. In some cases, where the desired Michael addition product was not obtained, we have actually seen the formation of a precipitate, which could be due to the formation of insoluble **L1** from the decomposition of the capsular assembly under the experimental condition. The ^1^H NMR spectrum of the precipitated mass was almost similar to the ^1^H NMR of pure **L1** ([Figure S8](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01780/suppl_file/ao8b01780_si_001.pdf)). This result indicated that the precipitate was actually insoluble **L1**, which might have formed from the decomposition of **C1**. On the other hand, when a homogeneous combination of **L1** and TBAHCO~3~ (as 10 mol % catalyst) in DCM was used in the above Michael addition reaction, ≈30% yield of the product was obtained after 1 h, which was much lower and slower than that observed in case of **C1**. Similarly, when another homogeneous combination of **L1** and (TBA)~2~CO~3~ (prepared from an equimolar mixture of TBAHCO~3~ and TBAOH in DMSO and used as 10 mol % catalyst) in DMSO was used in the above Michael addition reaction, ≈53% yield of the product was obtained after 1 h, which was also much lower and slower than that observed in case of **C1**. Thus, both the above model experiments proved the significant role and necessity of capsular cavity in the course of the reaction. Unfortunately, unlike our previous report with **L1**,^[@cit8e]^ as we could not prepare a similar model capsule without a bridgehead nitrogen atom, we could not determine the role of the bridgehead nitrogen atom in our present study. As the acidic urea peaks of **C1** were very broad and practically unrecognizable because of prior interaction with CO~3~^2--^, we could not determine the nature of interaction of reactants/reaction intermediates with the urea protons of **C1** from ^1^H NMR. However, from the previous results^[@cit8e]^ and general nature of urea group toward anionic species, it is expected that the anionic intermediate (formed after Michael addition) can be stabilized by H-bonding interaction with urea moiety of **L1**. In order to confirm that the capsular assembly remained stable throughout the reaction, we performed diffusion-ordered spectroscopy-NMR experiment of the pure capsular catalyst and catalyst solution after completion of the reaction. All the diffusion coefficient data are provided in the supporting information ([Figures S9--S11](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01780/suppl_file/ao8b01780_si_001.pdf)). The diffusion coefficient value of the pure catalyst before the reaction was 1.16 × 10^--9^ m^2^/s. After completion of reaction, the diffusion coefficient values were 1.04 × 10^--9^ and 2.93 × 10^--9^ m^2^/s in DMSO-*d*~6~ and CDCl~3~, respectively. Thus, the diffusion coefficient values were almost same in DMSO-*d*~6~ before and after the reaction, which indicated that catalytic species were same before and after the reaction. A nearly-three-times-higher diffusion coefficient value of the catalyst in CDCl~3~ also refers to the same catalytic species according to the Stokes Einstein equation (*D* ∝ 1/η for a molecule in different medium where *D* is the diffusion coefficient of the species and η is the viscosity coefficient of the medium) as DMSO-*d*~6~ has a nearly-three-times-higher η value as compared to CDCl~3~. As the catalyst is known to form a 1:2 (H/G) complex with CO~3~^2--^ in DMSO solution,^[@ref17]^ similar/complementary values of diffusion coefficients of the catalyst in different medium after the reaction indicated that the capsular assembly remained intact throughout the reaction. As we did not have enough evidence of the free pure capsular assembly, **C1** in CDCl~3~, we have taken parameters of free pure **C1** in DMSO solvent \[where it is proved to exist as a 1:2 (H/G) complex\] as an initial reference for the existence of capsular assembly. One indirect evidence was the homogeneous nature of the solution, which would have turned heterogeneous if **C1** decomposed to form **L1**, which is insoluble in DCM and CHCl~3~.

With all the above experimental results, we have proposed a simplified plausible mechanism ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}). At first, the catalyst activates both electrophilic nitro-olefins and nucleophilic ethyl acetoacetate via hydrogen bonding and deprotonation, respectively, inside the capsular assembly (step 1, [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}). After that, the enolate attacks the nitro-olefin to generate an intermediate, **D** (step 2, [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}), which probably gets stabilized by the surrounding six urea moieties via formation of hydrogen bonding interaction, which minimizes the activation energy of the reaction and thus accelerates the reaction. The formation of an anionic intermediate is supported by the positive ρ value of 0.4. This intermediate finally abstracts a proton from HCO~3~^--^ to form product **4a** (step 3, [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}), which probably comes out from the capsule because of poor fitting inside the capsule along with the regeneration of the capsular catalyst.

![Proposed mechanism for the present Michael addition reaction.](ao-2018-01780q_0005){#fig5}

3. Conclusions {#sec3}
==============

In summary, we have synthesized and utilized the dimeric capsular assembly of hexaurea for efficient and fast Michael addition reactions between unsubstituted/substituted β-nitrostyrenes with several activated Michael donors such as 1,3 diketone, ketoester, diester, and cyanoester under ambient conditions to produce the Michael adduct in excellent yields. The dimeric capsular assembly showed superior catalytic efficiency in terms of decrease in catalyst loading, use of conventional solvent, and drastic decrease in reaction time as compared to its monomeric analogue, **L1**. We have shown the role of dimeric capsular assembly in the reaction by performing some model reactions and proposed a simple plausible mechanism for the product formation from the kinetic studies. Utilization of this type of purely organic capsular assembly in organocatalysis could be very useful in development of cavity-based organocatalysis for better efficiency and selectivity. We are currently focusing on the detailed kinetic studies with other similar capsular catalysts, which would be very useful to demonstrate the detailed mechanistic route of this type of Michael addition reactions.

4. Experimental Section {#sec4}
=======================

4.1. General Comments {#sec4.1}
---------------------

A Bruker 300 MHz NMR instrument was used to record all the spectra. Chemical shifts were reported in parts per million from tetramethylsilane (TMS) with the solvent resonance as the internal standard (CHCl~3~: δ = 7.26 ppm). The pattern of reported data is as follows: chemical shifts, multiplicity (s = singlet, d = doublet, dd = double doublet, t = triplet, q = quartet, br = broad, m = multiplet), integration, and coupling constant (Hz). ^13^C NMR spectra were recorded at 75 MHz with proton decoupling. Chemical shifts were reported in parts per million from TMS with the solvent resonance as the internal standard (CHCl~3~: δ 77.0 ppm). Chromatographic purifications were done with either a 60--120 or a 100--200 mesh silica gel. For reaction monitoring, precoated silica gel 60 F254 TLC sheets were used. DCM was dried with CaH~2~ and used for all the reactions.

4.2. Purification and Analytical Data of All Compounds {#sec4.2}
------------------------------------------------------

### 4.2.1. Preparation of Catalyst, **C1**, and **C2** {#sec4.2.1}

The catalysts were prepared as reported previously.^[@ref17]^

### 4.2.2. General Procedure for Preparation of β-Nitro Styrene (**2a--2d**) {#sec4.2.2}

Nitromethane (12.0 mmol), aldehyde (10.0 mmol), and ammonium acetate (6.0 mmol) were added to 7 mL of glacial acetic acid. The solution was refluxed for 6 h and then poured into ice water, and after that, the solution was extracted with DCM (2 × 20 mL). The extracted solution was washed with brine and then dried over Na~2~SO~4~, filtered, and evaporated under reduced pressure. The obtained residue was purified by silica gel column chromatography using hexane and ethyl acetate as eluent (5:1).

### 4.2.3. General Procedure for the Michael Addition Reaction {#sec4.2.3}

A mixture of carbon nucleophiles (0.75 mmol), β-nitrostyrene (0.25 mmol), and catalyst **C1** (1 mol %) was taken in 2 mL of DCM and stirred at room temperature. The progress of the reaction was monitored by TLC, which suggested the completion of almost all the reactions within 5 min. After completion of the reaction, the solution was extracted 2--3 times with water. After that, the organic layer was separated, dried over anhydrous sodium sulfate, and then concentrated under vacuum. The obtained residue was purified by column chromatography on a silica gel (60--120 mesh, ethyl acetate/hexane mixture) to afford pure Michael addition products.

### 4.2.4. All Kinetic Procedures and Relevant Plots {#sec4.2.4}

#### 4.2.4.1. Determination of Order of Reaction wrt Nitrostyrene {#sec4.2.4.1}

β-nitrostyrene (0.016 mmol), **2a** (2.4 mg), in 450 μL of CDCl~3~ was mixed with 0.00016 mmol (1 mol %) of **C1** (taken from stock solution in CDCl~3~). 1,3,5-Trimethoxybenzene (2 mg) was used as an internal reference. This mixture was kept at 0 °C, and then excess of ethyl acetoacetate, **3a** (0.16 mmol, 25 μL), was added into the solution at 0 °C. Several such different NMR tubes were prepared for monitoring the progress of the reaction from time to time. Proceeding of the addition reaction was monitored by analysis of ^1^H NMR of each NMR tube after different increasing time intervals by integration with respect to the internal standard. Fitting of data for plot of log(*C*~0~/*C*~*t*~) versus time gives the order of reaction wrt **2a**.

#### 4.2.4.2. Determination of Rate Constants {#sec4.2.4.2}

β-nitrostyrenes (0.016 mmol) (**2a**, **2b**, **2c**, **2d**) in 450 μL of CDCl~3~ was mixed with 0.00016 mmol of **C1** (taken from stock solution in CDCl~3~). 1,3,5-Trimethoxybenzene (2 mg) was used as an internal reference. This mixture was kept at 0 °C and then excess of ethyl acetoacetate, **3a** (0.16 mmol, 25 μL), was added into the solution at 0 °C. Several such different NMR tubes were prepared for monitoring the progress of the reaction from time to time. Proceeding of the addition reaction was monitored by analysis of ^1^H NMR of each NMR tube after different increasing time intervals by integration with respect to the internal standard. Fitting of data for plot of log(*C*~0~/*C*~*t*~) versus time gives the order of reaction wrt **2a**, **2b**, **2c**, **2d**. Fitting of data for plot of log(*C*~0~/*C*~*t*~) versus time yielded a straight line from where the rate constant is calculated in the following way: rate constant, *K* = (2.303 × slope).

#### 4.2.4.3. Determination of Order of Reaction wrt Nitrostyrene {#sec4.2.4.3}

β-nitrostyrene (1.1 mmol), **2a** (2.4 mg), was mixed with 0.001 mmol (1 mol %) of **C1** (taken from stock solution) in 450 μL of CDCl~3~. 1,3,5-Trimethoxybenzene (8 mg) was used as an internal reference. This mixture was kept at 0 °C and then ethyl acetoacetate, **3a** (0.0125 mmol, 1.6 μL), was added into the solution at 0 °C. Several such different NMR tubes were prepared for monitoring the progress of the reaction from time to time. Proceeding of the addition reaction was monitored by analysis of ^1^H NMR of each NMR tube after different increasing time intervals by integration with respect to the internal standard. Fitting of data for plot of log(*C*~0~/*C*~*t*~) versus time gives the order of reaction wrt **3a**.

### 4.2.5. Purification of Michael Addition Products {#sec4.2.5}

**4a**: Purification by column chromatography (9:1 = hexane/ethylacetate) afforded **4a** as a white solid (66 mg, 97%, wrt 0.25 mmol scale). Analytical data matched with previously reported values. (dr = 1.3:1, determined by ^1^H NMR).

Ethyl-2-acetyl-4-nitro-3-phenylbutanoate (**4a**): (dr = 1.3: 1, de = 13%, determined by ^1^H NMR). ^1^H NMR (300 MHz, CDCl~3~): δ 7.30--7.27 (m, 3H), 7.21--7.18 (m, 2H), 4.84--4.74 (m, 2H), 4.25--4.17 (m, 1.8H), 4.12 (d, *J* = 9.5 Hz, 0.6H), 4.03 (d, *J* = 9.5 Hz, 0.4H), 3.98--3.94 (m, 1.2H), 2.30--2.05 (s, 3H), 1.30 (t, *J* = 6.9 Hz, 1.2H), 1.02 (t, *J* = 7.2 Hz, 1.8H); ^13^C NMR (75 MHz, CDCl~3~): 201.2, 200.4, 167.6, 166.9, 136.5, 136.5, 129.2, 129.0, 128.4, 128.3, 128.1, 78.0, 77.9, 62.3, 62.1, 62.0, 61.8, 42.6, 42.4, 30.3, 30.1, 14.1, 13.8 ppm; DEPT-135 NMR: 129.0 (CH), 128.8 (CH), 128.3 (CH), 127.9 (CH), 127.8 (CH), 77.9 (CH~2~), 77.7 (CH~2~), 62.1 (CH~2~), 61.9 (CH~2~), 61.9 (CH), 61.6 (CH), 42.5 (CH), 42.2 (CH), 30.2 (CH~3~), 30.0 (CH~3~), 13.9 (CH~3~), 13.6 (CH~3~).

**4b**: Purification by column chromatography (9:1 = hexane/ethylacetate) afforded **4b** as a white solid (68 mg, 95%, wrt 0.25 mmol scale). Analytical data matched with previously reported values. (dr = 1:1, determined by ^1^H NMR).

Ethyl 2-acetyl-4-nitro-3-*p*-tolylbutanoate (**4b**): (dr = 1: 1, de = 0%, determined by ^1^H NMR). ^1^H NMR (300 MHz, CDCl~3~): δ 7.11--7.05 (m, 4H), 4.81--4.71 (m, 2H), 4.25--4.07 (m, 2.5H), 4.01--3.93 (m, 1.5H), 2.28 (s, 4.6H), 2.04 (s, 1.4H), 1.27 (t, *J* = 7.2 Hz, 1.5H), 1.02 (t, *J* = 7.2 Hz, 1.5H); ^13^C NMR (75 MHz, CDCl~3~): 201.0, 200.1, 167.3, 166.6, 137.8, 137.7, 133.0, 132.9, 129.5, 129.3, 127.5, 127.4, 77.7, 61.8, 61.7, 61.6, 61.4, 41.9, 41.6, 30.0, 29.8, 20.7, 13.6, 13.4 ppm; DEPT-135 NMR: 129.8 (CH), 129.6 (CH), 127.8 (CH), 127.7 (CH), 78.01 (CH~2~), 62.2 (CH~2~), 62.0 (CH), 61.9 (CH~2~), 61.7 (CH), 42.3 (CH), 42.0 (CH), 30.3 (CH~3~), 30.1 (CH~3~), 21.1 (CH~3~), 14.0 (CH~3~), 13.7 (CH~3~).

**4c**: Purification by column chromatography (9:1 = hexane/ethylacetate) afforded **4c** as a white solid (71 mg, 94%, wrt 0.25 mmol scale). Analytical data matched with previously reported values. (dr = 1.2:1, determined by ^1^H NMR).

Ethyl 2-acetyl-3-(4-methoxyphenyl)-4-nitrobutanoate (**4c**): (dr = 1.2: 1, de = 9%, determined by ^1^H NMR). ^1^H NMR (300 MHz, CDCl~3~): δ 7.12--7.09 (m, 2H), 6.83--6.80 (m, 2H), 4.80--4.68 (m, 2H), 4.25--4.04 (m, 2.5H), 4.00--3.93 (m, 1.5H), 3.75 (s, 3H), 2.28 (s, 1.5H), 2.04 (s, 1.5H), 1.27 (t, *J* = 7.2 Hz, 1.7H), 1.02 (t, *J* = 7.2 Hz, 1.3H); ^13^C NMR (75 MHz, CDCl~3~): 201.4, 200.6, 167.7, 167.0, 159.5, 159.4, 129.2, 129.1, 128.3, 128.1, 114.6, 114.4, 78.2, 78.1, 62.3, 62.2, 62.0, 61.9, 55.3, 42.1, 41.7, 30.4, 30.2, 14.1, 13.8 ppm; DEPT-135 NMR: 128.2 (CH), 128.1 (CH), 113.6 (CH), 113.3 (CH), 77.16 (CH~2~), 77.13 (CH~2~), 61.2 (CH), 61.2 (CH~2~), 61.0 (CH~2~), 60.8 (CH), 54.25 (OMe), 41.0 (CH~3~), 40.7 (CH~3~), 29.3 (CH~3~), 29.1 (CH~3~).

**4d**: Purification by column chromatography (9:1 = hexane/ethylacetate) afforded **4d** as a colorless liquid (76 mg, 96%, wrt 0.25 mmol scale). Analytical data matched with previously reported values. (dr = 1.4:1, determined by ^1^H NMR).

Ethyl 2-acetyl-3-(4-chlorophenyl)-4-nitrobutanoate (**4d**): (dr = 1:1, de = 16%, determined by ^1^H NMR). ^1^H NMR (300 MHz, CDCl~3~): δ 7.34--7.26 (m, 2H), 7.16--7.09 (m, 2H), 4.85--4.69 (m, 2H), 4.26--4.16 (m, 1.8H), 4.08 (d, *J* = 10 Hz, 0.6H), 4.02--3.97 (m, 1.6H), 2.31 (s, 1.6H), 2.09 (s, 1.4H), 1.17 (t, *J* = 7.0 Hz, 1.5H), 0.88 (t, *J* = 7.2 Hz, 1.5H); ^13^C NMR (75 MHz, CDCl~3~): 200.9, 200.1, 167.4, 166.7, 135.1, 135.1, 134.4, 134.3, 129.5, 129.4, 129.3, 129.2, 77.8, 62.5, 62.2, 61.9, 61.6, 41.9, 41.8, 30.4, 30.1, 14.1, 13.8 ppm; DEPT-135 NMR: 129.4 (CH), 129.3 (CH), 129.2 (CH), 77.7 (CH~2~), 77.5 (CH~2~), 62.4 (CH~2~), 62.1 (CH~2~), 61.8 (CH), 61.5 (CH), 41.8 (CH), 41.7 (CH), 30.3 (CH~3~), 30.1 (CH~3~), 13.9 (CH~3~), 13.7 (CH~3~).

**5a**: Purification by column chromatography (8:1 = hexane/ethylacetate) afforded **5a** as a white solid (61 mg, 88%, wrt 0.25 mmol scale). Analytical data matched with previously reported values.

3-(2-Nitro-1-phenylethyl)pentane-2,4-dione (**5a**): (dr = 1:1, de = 0%, determined by ^1^H NMR) ^1^H NMR (300 MHz, CDCl~3~): δ 7.35--7.29 (m, 3H), 7.20--7.17 (m, 2H), 4.65--4.62 (m, 2H), 4.37 (d, *J* = 10.8 Hz, 1H), 4.27--4.24 (m, 1H), 2.30 (s, 3H), 1.94 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~): 201.9, 201.1, 136.2, 129.5, 128.7, 128.1, 78.3, 70.8, 42.9, 30.5, 29.8, 29.7 ppm; DEPT-135: 129.3 (CH), 128.5 (CH), 127.9 (CH), 78.2 (CH~2~), 70.7 (CH), 42.8 (CH), 30.4 (CH~3~), 29.6 (CH~3~).

**5c**: Purification by column chromatography (8:1 = hexane/ethylacetate) afforded **5c** as a white solid (65 mg, 85%, wrt 0.25 mmol scale). Analytical data matched with previously reported values.

3-(1-(4-Methoxyphenyl)-2-nitroethyl)pentane-2,4-dione (**5c**): (dr = 1: 1, de = 0%, determined by ^1^H NMR) ^1^H NMR (300 MHz, CDCl~3~): δ 7.08 (d, *J* = 7.5 Hz, 2H), 6.82 (d, *J* = 8.5 Hz, 2H), 4.56 (d, *J* = 6.5 Hz, 2H), 4.30 (d, *J* = 11.0 Hz, 1H), 4.20--4.16 (m, 1H), 3.74 (s, 3H), 2.25 (s, 3H), 1.92 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~): 202.0, 201.3, 159.6, 129.2, 127.7, 114.7, 78.5, 70.9, 55.3, 42.2, 30.5, 29.6 ppm; DEPT-135 NMR: 128.3 (CH), 113.9 (CH), 77.7 (CH~2~), 70.1 (CH), 54.5 (OMe), 41.4 (CH), 29.6 (CH~3~), 28.74 (CH~3~).

**6b**: Purification by column chromatography (9:1 = hexane/ethylacetate) afforded **6b** as a white solid (71 mg, 92%, wrt 0.25 mmol scale. Analytical data matched with previously reported values.

Diethyl 2-(2-nitro-1-(*p*-tolyl)ethyl)malonate (**6b**): (dr = 1.2:1, de = 0%, determined by ^1^H NMR) ^1^H NMR (300 MHz, CDCl~3~): δ = 7.05 (s, 4H), 5.08--4.94 (m, 2H), 4.38--4.33 (m, 3H), 4.19--4.12 (m, 2H), 3.96--3.93 (d, 1H), 2.22 (s, 3H), 1.43--1.38 (t, 4H), 1.23--1.19 (t, 3H); ^13^C NMR (75 MHz, CDCl~3~): 167.6, 166.9, 138.1, 133.2, 129.2, 127.9, 62.2, 61.9, 55.2, 42.7, 21.1, 14.1, 13.8 ppm; DEPT-135 NMR: 129.6 (CH), 127.8 (CH), 77.79 (CH~2~), 61.13 (CH~2~), 61.2 (CH~2~), 55.0 (CH), 42.63 (CH~3~), 21.0 (CH~3~), 13.9 (CH~3~), 13.7 (CH~3~).

**6c**: Purification by column chromatography (9:1 = hexane/ethylacetate) afforded **6b** as a white solid (71 mg, 90%, wrt 0.25 mmol scale). Analytical data matched with previously reported values.

Diethyl 2-(1-(4-methoxyphenyl)-2-nitroethyl)malonate (**6c**): (dr = 1.1:1, de = 5%, determined by ^1^H NMR) ^1^H NMR (300 MHz, CDCl~3~): δ = 7.16--7.13 (d, 2H), 6.83--6.81 (d, 2H), 4.91--4.76 (m, 2H), 4.25--4.13 (m, 3H), 4.04--3.97 (q, 2H), 3.79--3.76 (m, 4H), 1.28--1.23 (t, 3H), 1.08--1.04 (t, 3H); ^13^C NMR (75 MHz, CDCl~3~): 167.6, 167.0, 159.5, 129.2, 128.1, 114.4, 78.0, 62.2, 61.9, 55.3, 55.2, 42.4, 14.0, 13.9, 133.2, 129.2, 127.9, 62.2, 61.9, 55.2, 42.7, 21.1, 14.1, 13.8 ppm; DEPT-135 NMR: 129.1 (CH), 114.2 (CH), 77.9 (CH~2~), 62.1 (CH~2~), 61.8 (CH~2~), 55.2 (CH), 55.1 (CH) 42.3 (CH~3~), 13.9 (CH~3~), 13.7 (CH~3~).

**7b**: Purification by column chromatography (8:1 = hexane/ethylacetate) afforded **7b** as a colorless liquid (63 mg, 84%, wrt 0.25 mmol scale). Analytical data matched with previously reported values. (dr = 1: 1, determined by ^1^H NMR).

Ethyl 2-cyano-4-nitro-3-*p*-tolylbutanoate (**7b**): (dr = 1:1, de = 0%, determined by ^1^H NMR). ^1^H NMR (300 MHz, CDCl~3~): δ 7.23--7.16 (m, 4H), 5.03--4.73 (m, 2.2H), 4.28--4.08 (m, 3.4H), 3.90 (d, *J* = 5.7 Hz, 0.4H), 2.33 (s, 3H), 1.23 (t, *J* = 7.2 Hz, 1.5H), 1.16 (t, *J* = 7.2 Hz, 1.5H); ^13^C NMR (75 MHz, CDCl~3~): 164.1, 163.9, 139.5, 139.4, 130.2, 130.1, 127.9, 127.5, 114.4, 76.6, 76.2, 63.7, 63.4, 42.9, 42.6, 41.9, 41.8, 29.8, 21.2, 13.9 ppm; DEPT-135 NMR: 129.2 (CH), 129.1 (CH), 126.9 (CH), 126.4 (CH), 75.5 (CH~2~), 75.1 (CH~2~), 62.6 (CH~2~), 62.4 (CH~2~), 41.9 (CH), 41.5 (CH), 40.8 (CH), 40.7 (CH), 28.7 (CH~2~), 20.2 (CH~3~), 12.8 (CH~3~).

**7c**: Purification by column chromatography (8:1 = hexane/ethylacetate) afforded **7c** as a colorless liquid (66 mg, 85%, wrt 0.25 mmol scale). Analytical data matched with previously reported values. (dr = 1:1, determined by ^1^H NMR).

Ethyl 2-cyano-3-(4-methoxyphenyl)-4-nitrobutanoate (**7c**): (dr = 1:1, de = 0%, determined by ^1^H NMR). ^1^H NMR (300 MHz, CDCl~3~): δ 7.25--7.20 (m, 2H), 6.88 (d, *J* = 8.7 Hz, 2H), 4.99--4.71 (m, 2.2H), 4.24--4.07 (m, 3.4H), 3.89 (d, *J* = 3.0 Hz, 0.4H), 3.78 (s, 3H), 1.23 (t, *J* = 7.2 Hz, 1.5H), 1.16 (t, *J* = 7.2 Hz, 1.5H); ^13^C NMR (75 MHz, CDCl~3~): 164.1, 163.9, 160.3, 160.2, 129.3, 128.9, 126.3, 125.4, 114.9, 114.7, 114.6, 114.5, 76.6, 76.3, 63.6, 63.4, 55.4, 42.6, 42.2, 41.9, 41.8, 13.9 ppm; DEPT-135 NMR: 128.3 (CH), 127.8 (CH), 113.8 (CH), 113.7 (CH), 75.6 (CH~2~), 75.3 (CH~2~), 62.6 (CH~2~), 62.4 (CH~2~), 54.3 (OMe), 41.6 (CH), 41.2 (CH), 40.9 (CH), 40.8 (CH), 12.9 (CH~3~).

**7d**: Purification by column chromatography (8:1 = hexane/ethylacetate) afforded **7d** as a colorless liquid (70 mg, 87%, wrt 0.25 mmol scale). Analytical data matched with previously reported values. (dr = 1:1, determined by ^1^H NMR).

Ethyl 3-(4-chlorophenyl)-2-cyano-4-nitrobutanoate (**7d**): (dr = 1:1, de = 0%, determined by ^1^H NMR). ^1^H NMR (300 MHz, CDCl~3~): δ 7.38--7.34 (m, 2H), 7.30--7.24 (m, 2H), 5.03--4.73 (m, 2.2H), 4.26--4.09 (m, 3.4H), 3.89 (d, *J* = 5.7 Hz, 0.4H), 1.24 (t, *J* = 7.2 Hz, 1.5H), 1.17 (t, *J* = 7.2 Hz, 1.5H); ^13^C NMR (75 MHz, CDCl~3~): 163.8, 163.6, 133.1, 132.1, 129.9, 129.8, 129.7, 129.6, 129.1, 128.9, 114.3, 114.2, 76.6, 76.2, 75.9, 63.9, 63.7, 42.6, 42.2, 41.6, 41.4, 13.9 ppm; DEPT-135 NMR: 128.8 (CH), 128.6 (CH), 128.5 (CH), 128.1 (CH), 75.5 (CH~2~), 75.2 (CH~2~), 74.8 (CH~2~), 62.9 (CH~2~), 62.6 (CH~2~), 41.5 (CH), 41.1 (CH), 40.5 (CH), 40.4 (CH), 12.9 (CH~3~).

**8a**: Purification by column chromatography (10:1 = hexane/ethylacetate) afforded **8a** as a colorless liquid (70 mg, 90%, wrt 0.25 mmol scale). Analytical data matched with previously reported values. (dr = 2.3:1, determined by ^1^H NMR).

Ethyl 1-(2-nitro-1-phenylethyl)-2-oxo cyclopentanecarboxylate (**8a**): (dr = 1:1, de = 0%, determined by ^1^H NMR). ^1^H NMR (300 MHz, CDCl~3~): δ 7.29--7.23 (m, 5H), 5.28 (dd, *J* = 10.8 Hz, 13.5 Hz, 0.3H), 5.19 (dd, *J* = 3.9 Hz, 13.5 Hz, 0.7H), 5.00 (dd, *J* = 10.8 Hz, 13.5 Hz, 0.7H), 4.81 (dd, *J* = 3.6 Hz, 13.5 Hz, 0.3H), 4.27--4.14 (m, 2H), 4.08 (dd, *J* = 3.9 Hz, 10.8 Hz, 1H), 2.38--2.30 (m, 2H), 2.02--1.80 (m, 4H), 1.25 (t, *J* = 7.2 Hz, 3H); ^13^C NMR (75 MHz, CDCl~3~): 215.6, 212.5, 171.1, 169.4, 135.6, 135.5, 129.4, 129.3, 129.1, 128.9, 128.5, 128.4, 77.1, 76.6, 62.5, 62.4, 62.3, 47.4, 46.3, 39.6, 38.0, 33.6, 31.3, 19.7, 19.4, 14.1, 14.0 ppm; DEPT-135 NMR: 129.3 (CH), 129.2 (CH), 129.0 (CH), 128.8 (CH), 128.4 (CH), 77.0 (CH~2~), 76.5 (CH~2~), 62.3 (CH~2~), 62.2 (CH~2~), 47.3 (CH), 46.2 (CH), 39.5 (CH~2~), 37.9 (CH~2~), 33.5 (CH~2~), 31.2 (CH~2~), 19.6 (CH~2~), 19.4 (CH~2~), 14.0 (CH~3~), 13.9 (CH~3~).

**8b**: Purification by column chromatography (10:1 = hexane/ethylacetate) afforded **8b** as a colorless liquid (69 mg, 88%, wrt 0.25 mmol scale). Analytical data matched with previously reported values. (dr = 2:1, determined by ^1^H NMR).

Ethyl 1-(2-nitro-1-*p*-tolylethyl)-2 oxo-cyclopentanecarboxylate (**8b**): (dr = 1:1, de = 0%, determined by ^1^H NMR). ^1^H NMR (300 MHz, CDCl~3~): δ 7.13--7.06 (m, 4H), 5.25 (dd, *J* = 11.4 Hz, 13.5 Hz, 0.4H), 5.11 (dd, *J* = 4.2 Hz, 13.5 Hz, 0.6H), 4.98 (dd, *J* = 11.4 Hz, 13.5 Hz, 0.6H), 4.81 (dd, *J* = 4.2 Hz, 13.5 Hz, 0.4H), 4.22--4.15 (m, 2.4H), 4.02 (dd, *J* = 3.9 Hz, 10.8 Hz, 0.6H), 2.37--2.28 (m, 5H), 2.04--1.72 (m, 4H), 1.29--1.23 (m, 3H); ^13^C NMR (75 MHz, CDCl~3~): 215.7, 212.5, 171.2, 169.4, 138.2, 138.1, 132.4, 132.2, 129.7, 129.5, 129.2, 129.1, 76.6, 62.6, 62.32, 62.26, 62.2, 47.0, 45.9, 39.6, 38.1, 38.0, 33.6, 31.1, 21.1, 21.0, 19.7, 19.4, 14.2, 14.0 ppm; DEPT-135 NMR: 129.7 (CH), 129.5 (CH), 129.2 (CH), 129.0 (CH), 77.0 (CH~2~), 76.5 (CH~2~), 62.2 (CH~2~), 62.1 (CH~2~), 47.0 (CH), 45.9 (CH), 39.6 (CH~2~), 38.1 (CH~2~), 37.9 (CH~2~), 33.5 (CH~2~), 31.0 (CH~2~), 21.02 (CH~3~), 21.0 (CH~3~), 19.6 (CH~2~), 19.4 (CH~2~), 14.2 (CH~3~), 14.0 (CH~3~).

**8c**: Purification by column chromatography (10:1 = hexane/ethylacetate) afforded **8c** as a colorless liquid (70 mg, 86%, wrt 0.25 mmol scale). Analytical data matched with previously reported values. (dr = 1:1, determined by ^1^H NMR).

Ethyl 1-(1-(4-methoxyphenyl)-2-nitroethyl)-2-oxocyclopentane-carboxylate (**8c**): (dr = 1:1, de = 0%, determined by ^1^H NMR). ^1^H NMR (300 MHz, CDCl~3~): δ 7.16 (d, *J* = 8.7 Hz, 1H), 7.09 (d, *J* = 8.8 Hz, 1H), 6.82 (d, *J* = 6.9 Hz, 2H), 5.24 (dd, *J* = 11.4 Hz, 13.5 Hz, 0.5H), 5.11 (dd, *J* = 4.5 Hz, 13.5 Hz, 0.5H), 4.95 (dd, *J* = 11.4 Hz, 13.5 Hz, 0.5H), 4.80 (dd, *J* = 3.3 Hz, 13.5 Hz, 0.5H), 4.23--4.10 (m, 2.5H), 4.04 (dd, *J* = 3.9 Hz, 10.8 Hz, 0.5H), 3.76 (s, 3H), 2.38--2.28 (m, 2H), 2.02--1.78 (m, 4H), 1.26 (t, *J* = 8.1 Hz, 3H); ^13^C NMR (75 MHz, CDCl~3~): 215.8, 212.6, 171.3, 169.5, 159.6, 159.5, 130.6, 130.4, 127.3, 127.2, 114.5, 114.3, 76.7, 62.7, 62.4, 62.31, 62.27, 55.3, 46.8, 45.7, 39.7, 38.1, 33.7, 31.2, 19.7, 19.5, 14.14, 14.10 ppm; DEPT-135 NMR: 130.5 (CH), 130.3 (CH), 114.3 (CH), 114.1 (CH), 77.1 (CH~2~), 76.6 (CH~2~), 62.2 (CH~2~), 62.1 (CH~2~), 55.2 (OMe), 46.6 (CH), 45.5 (CH), 39.6 (CH~2~), 37.9 (CH~2~), 33.6 (CH~2~), 31.0 (CH~2~), 19.6 (CH~2~), 19.4 (CH~2~), 14.0 (CH~3~), 13.9 (CH~3~).

**8d**: Purification by column chromatography (10:1 = hexane/ethylacetate) afforded **8d** as a colorless liquid (80 mg, 85%, wrt 0.25 mmol scale). Analytical data matched with previously reported values. (dr = 4.5:1, determined by ^1^H NMR).

Ethyl 1-(1-(4-chlorophenyl)-2-nitroethyl)-2-oxocyclopentane-carboxylate (**8d**): (dr = 1:1, de = 0%, determined by ^1^H NMR). ^1^H NMR (300 MHz, CDCl~3~): δ 7.30--7.20 (m, 4H), 5.24 (dd, *J* = 11.4 Hz, 13.5 Hz, 0.2H), 5.15 (dd, *J* = 3.9 Hz, 10.8 Hz, 0.8H), 4.96 (dd, *J* = 11.1 Hz, 13.5 Hz, 0.8H), 4.78 (dd, *J* = 3.3 Hz, 13.5 Hz, 0.2H), 4.22--4.15 (m, 2.2H), 4.02 (dd, *J* = 3.9 Hz, 10.5 Hz, 0.8H), 2.43--2.29 (m, 2H), 2.11--1.80 (m, 4H), 1.25 (t, *J* = 7.2 Hz, 3H); ^13^C NMR (75 MHz, CDCl~3~): 215.3, 212.3, 170.8, 169.4, 134.6, 134.4, 134.2, 134.1, 130.9, 130.7, 129.3, 129.1, 76.8, 76.4, 62.5, 62.4, 62.3, 46.7, 45.7, 39.5, 37.9, 33.5, 31.5, 19.7, 19.5, 14.1, 14.0 ppm; DEPT-135 NMR: 130.8 (CH), 130.6 (CH), 129.2 (CH), 129.0 (CH), 76.7 (CH~2~), 76.3 (CH~2~), 62.4 (CH~2~), 62.3 (CH~2~), 46.6 (CH), 45.6 (CH), 39.4 (CH~2~), 37.8 (CH~2~), 33.4 (CH~2~), 31.4 (CH~2~), 19.6 (CH~2~), 19.4 (CH~2~), 14.0 (CH~3~), 13.9 (CH~3~).

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.8b01780](http://pubs.acs.org/doi/abs/10.1021/acsomega.8b01780).Kinetic studies and characterization details of all the products by NMR ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01780/suppl_file/ao8b01780_si_001.pdf))
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